| 标题 |
 Prospective randomized phase II trial to assess the efficacy and safety of neo-adjuvant olaparib/carboplatin (OC) in comparison to docetaxel/epirubicin/cyclophosphamide (TAC) in patients with early triple-negative breast cancer (TNBC) with homologous recombination deficiency (HRD): Primary results from the ABCSG 45 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of Clinical Oncology 作者：Christian F. Singer; Dominik Hlauschek; Daniel Egle; Zsuzsanna Bago-Horvath; Georg Pfeiler; et al 出版日期：2025-05-29 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
DW
v0id
Nole
xing_xing
cdercder
刘龙
舒适的如萱
凌凌
学术文献互助
YY
aajhajkahna
OK
dde
七听
潇洒的惋清
水煮电吹风
2052669099
arniu2008
MchemG
皖公网安备34019202002308
